No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs371399877 |
chr14:22203041-22203042 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs542417595 |
chr14:22203130-22203131 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs34576814 |
chr14:22203148-22203149 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs397853524 |
chr14:22203157-22203158 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs562352143 |
chr14:22203162-22203163 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs529741543 |
chr14:22203197-22203198 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs546682143 |
chr14:22203222-22203223 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs566318581 |
chr14:22203237-22203238 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs553493995 |
chr14:22203244-22203245 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs532150964 |
chr14:22203251-22203252 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs556690968 |
chr14:22203258-22203259 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs551792614 |
chr14:22203296-22203297 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs12590415 |
chr14:22203306-22203307 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
14 |
rs12590420 |
chr14:22203345-22203346 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
15 |
rs150761663 |
chr14:22203403-22203404 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs111885433 |
chr14:22203405-22203406 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs533991442 |
chr14:22203406-22203407 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs185887561 |
chr14:22203521-22203522 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs577129010 |
chr14:22203526-22203527 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs145322202 |
chr14:22203562-22203563 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs78231430 |
chr14:22203606-22203607 |
Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs114138928 |
chr14:22203616-22203617 |
Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs542583695 |
chr14:22203683-22203684 |
Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs562099757 |
chr14:22203716-22203717 |
Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs572602451 |
chr14:22203726-22203727 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs539916065 |
chr14:22203744-22203745 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs560180084 |
chr14:22203768-22203769 |
Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs190866689 |
chr14:22203830-22203831 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs2320056 |
chr14:22203869-22203870 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
30 |
rs562185027 |
chr14:22203887-22203888 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs570491969 |
chr14:22203923-22203924 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs531462925 |
chr14:22203928-22203929 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs548469530 |
chr14:22203962-22203963 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs568132432 |
chr14:22203970-22203971 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs534004760 |
chr14:22204065-22204066 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs183263626 |
chr14:22204108-22204109 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs147216496 |
chr14:22204146-22204147 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs534704565 |
chr14:22204151-22204152 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs539985450 |
chr14:22204182-22204183 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs115892427 |
chr14:22204185-22204186 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs370503658 |
chr14:22204199-22204200 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs536107160 |
chr14:22204243-22204244 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs553032190 |
chr14:22204272-22204273 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs140334349 |
chr14:22204282-22204283 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs572685763 |
chr14:22204304-22204305 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs186383893 |
chr14:22204336-22204337 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs564571215 |
chr14:22204377-22204378 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs576524746 |
chr14:22204382-22204383 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs545504956 |
chr14:22204390-22204391 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs113037741 |
chr14:22204417-22204418 |
Weak transcription Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|